Patent details
EP2293776 Title: FIBRINOGEN BEING FUNTIONALLY INTACT , STORAGE STABLE AND VIRUS-INACTIVATED
Basic Information
- Publication number:
- EP2293776
- PCT Application Number:
- PCT/AT/2009/000248
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP097686018
- PCT Publication Number:
- WO/2009/155626
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- German
- English Title of Invention:
- FIBRINOGEN BEING FUNTIONALLY INTACT , STORAGE STABLE AND VIRUS-INACTIVATED
- French Title of Invention:
- FIBRINOGEN ÉTANT FONTIONELLEMENT INTACT, STABLE AU STOCKAGE ET INACTIVÉ DE VIRUS
- German Title of Invention:
- LAGERSTABILES, FUNKTIONELL INTAKTES VIRUS-INAKTIVIERTES FIBRINOGEN
- SPC Number:
Dates
- Filing date:
- 22/06/2009
- Grant date:
- 02/03/2016
- EP Publication Date:
- 02/03/2016
- PCT Publication Date:
- 30/12/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/03/2011
- EP B1 Publication Date:
- 02/03/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 22/06/2016
- Expiration date:
- 22/06/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/02/2016
- Name:
- Bio-Products & Bio-Engineering Aktiengesellschaft
- Address:
- Mariannengasse 10, 1090 Wien, Austria (AT)
Inventor
- Name:
- EIBL Johann
- Address:
- Austria (AT)
Priority
- Priority Number:
- 74830 P
- Priority Date:
- 17/02/1998
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 9/00;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|